Kinesiophobia in Prostate Cancer
Physical Activity, Fear of Falling, Fatigue and Functionality in Prostate Cancer
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aimed to investigate the effects of prostate cancer on patients' physical activity, kinesiophobia, fatigue and functionality. This research is a prospective study to be conducted on volunteer individuals between the ages of 40-75. People diagnosed with prostate cancer (study group) and healthy adults who have not been diagnosed with prostate cancer before (control group) will be included in the study. The demographic characteristics, physical activity levels and quality of life of all individuals participating in the study will be evaluated with an online form. In demographic data, physical, sociodemographic data such as age (years), height (cm), body weight (kg), body mass index (kg/m2) and disease-specific information will be recorded. Physical activity level will be measured with the International Physical Activity Survey short form (UFAA), fatigue with the Functional Evaluation of Chronic Disease Treatment-Fatigue Questionnaire, fear of movement with the Causes of Fear of Movement Questionnaire, and quality of life with the Functional Evaluation of Cancer Treatment-Prostate Version questionnaire (KHTFD-Y).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable prostate-cancer
Started Nov 2023
Shorter than P25 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2023
CompletedStudy Start
First participant enrolled
November 9, 2023
CompletedFirst Posted
Study publicly available on registry
November 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2023
CompletedJanuary 29, 2024
January 1, 2024
11 days
November 9, 2023
January 26, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
International Physical Activity Survey short form
The short form consists of 7 questions. The form provides information about the frequency and time spent in walking, moderate physical activity, and vigorous physical activity.
10 minutes
Functional Assessment of Fatigue Chronic Disease Treatment-Fatigue Questionnaire
It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.
10 minutes
Reasons for Fear of Movement Questionnaire
It allows the causes of kinesiophobia to be identified and both biological and psychological causes to be determined separately. The average of the scores obtained from the biological and physiological subscales gives the total score from the survey. A 5-point Likert scoring (1 = Totally disagree, 5 = Completely agree) is used in the scale. An individual's high score from the survey indicates that he/she has more fear of movement.
10 minutes
Functional Evaluation of Cancer Treatment-Prostate Version questionnaire
It consists of 13 questions that evaluate the level of fatigue that occurred during daily activities in the last 7 days. Scoring varies between 0-52. High scores indicate less fatigue.
10 minutes
Study Arms (2)
prostate group
EXPERIMENTALcontrol group
ACTIVE COMPARATORInterventions
assessment of physical activity, fatigue, fear of movement, and quality of life
Eligibility Criteria
You may qualify if:
- (for prostate cancer-study group)
- Being between the ages of 40-75
- Want to participate in the study
- Being able to read and write
- Being diagnosed with prostate cancer by a specialist physician,
- Being able to provide their mobility independently,
- (for healthy controls - control group)
- Being between the ages of 40-75
- Not having any previous cancer history and not having undergone cancer surgery
- Volunteering to participate in the study
You may not qualify if:
- Those with a previously known or accompanying diagnosis of dementia
- Not wanting to participate in the study
- The individual has a disease that may prevent him or her from understanding and completing the survey.
- Illiterates
- Those who do not want to participate in the research voluntarily
- Having active metastasis
- Having undergone chemotherapy and radiotherapy in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Selcuk University
Konya, Selcuklu, 42130, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Prof Dr
Study Record Dates
First Submitted
November 9, 2023
First Posted
November 14, 2023
Study Start
November 9, 2023
Primary Completion
November 20, 2023
Study Completion
December 4, 2023
Last Updated
January 29, 2024
Record last verified: 2024-01